Apicore US LLC.

Please contact us by phone or email to discuss new business opportunities.

Product Search : FDP Form:   And/Or   Name/Keyword:
View all Products
Miglustat
Product FDP Form: Solid Oral
FDP Presentation: Capsule
Apicore API Status: DMF Filed, 3/13
Apicore API Market Status: Pre Launch
DMF Status: C
Therapeautic category: Endocrine/Metabolic Agent
Dosage Form: Capsule
Route: Oral
RLD: Zavesca
Strengths: 100MG
Indication: Treatment of adults with type 1 Gaucher disease
Go To Products